{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:27:24Z","timestamp":1780964844828,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clindermatol.2021.01.018","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:19:01Z","timestamp":1617736741000},"page":"467-478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Learning from disease registries during a pandemic: Moving toward an international federation of patient registries"],"prefix":"10.1016","volume":"39","author":[{"given":"Dmitri","family":"Wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Alhusayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Arents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Apfelbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther A.","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laita","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Bloem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Castelo-Soccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Hruza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kappelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lara-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nekma","family":"Meah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon E.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satveer K.","family":"Mahil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McNicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelie","family":"Musters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis","family":"Spuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond J.","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"York","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2021.01.018_bib0001","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/bjd.17849","article-title":"A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis","volume":"181","author":"Yiu","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0002","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jamadermatol.2018.0183","article-title":"Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in BADBIR","volume":"154","author":"Mason","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0003","unstructured":"Medicine and Healthcare Products Regulatory Agency. Yellow Card. Available at: https:\/\/yellowcard.mhra.gov.uk. Accessed August 31, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0004","series-title":"Registries for Evaluating Patient Outcomes: A User's Guide. Third Edition. Two Volumes","author":"Gliklich","year":"2014"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2049-3258-72-35","article-title":"The EPIRARE proposal of a set of indicators and common data elements for the European platform for rare disease registration","volume":"72","author":"Taruscio","year":"2014","journal-title":"Arch Public Heal"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0006","series-title":"Methodological Guidelines and Recommendations for Efficient and Rational Governance of Patient Registries","author":"Zaletel","year":"2015"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0007","first-page":"1161","article-title":"PARENT joint action: increasing the added value of patient registries in a cross-border setting","volume":"192","author":"Megli\u010d","year":"2013","journal-title":"Stud Health Technol Inform"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1377\/hlthaff.2011.0762","article-title":"Use of 13 disease registries in 5 countries demonstrates the potential to use outcome data to improve health care's value","volume":"31","author":"Larsson","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0009","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2133.2008.08548.x","article-title":"Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis","volume":"158","author":"Leonardi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sder.2010.01.001","article-title":"Assessing long-term drug safety: lessons (re) learned from raptiva","volume":"29","author":"Seminara","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0011","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2133.2012.10835.x","article-title":"The British Association of Dermatologists\u2019 Biologic Interventions Register (BADBIR): design, methodology and objectives","volume":"166","author":"Burden","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0012","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000338572","article-title":"Challenges for synthesising data in a network of registries for systemic psoriasis therapies","volume":"224","author":"Ormerod","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0013","unstructured":"European Medicines Agency. MA patient registry initiative strategy and pilot phase. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/other\/initiative-patient-registries-strategy-pilot-phase_en.pdf. Accessed XX Month, 20XX."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0014","unstructured":"European Medicines Agency. Patient registry initiative\u2014Strategy and mandate of the Cross-Committee Task Force. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/other\/patient-registry-initiative-strategy-mandate-cross-committee-task-force_en.pdf. Accessed XX Month, 20XX."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/bjd.18452","article-title":"TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema","volume":"182","author":"Bosma","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0016","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.jid.2017.05.014","article-title":"The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: an initiative to harmonize data collection across national atopic eczema photo- and systemic therapy registries","volume":"137","author":"Spuls","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0017","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/jdv.13267","article-title":"Establishment of a European registry for hidradenitis suppurativa\/acne inversa by using an open source software","volume":"30","author":"Daxhelet","year":"2016","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0018","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/jdv.16132","article-title":"Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice","volume":"34","author":"Kimball","year":"2020","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0019","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/jid.2012.168","article-title":"Rangel Miller V. Significance of patient registries for dermatological disorders","volume":"132","author":"de Souza","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038145","article-title":"Generic outcome set for the international registry on Laser trEAtments in Dermatology (LEAD): a protocol for a Delphi study to achieve consensus on what to measure","volume":"10","author":"Fransen","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0021","unstructured":"Johns Hopkins University. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available at: https:\/\/coronavirus.jhu.edu\/map.html. Accessed August 31, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0022","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.jaad.2020.06.050","article-title":"International collaboration and rapid harmonization across dermatologic COVID-19 registries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0023","unstructured":"PsoProtectMe. Available at: https:\/\/psoprotectme.org\/. Accessed July 20, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0024","unstructured":"Global Hidradenitis Suppurative COVID-19 registry. Available at: https:\/\/hscovid.ucsf.edu. Accessed July 21, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0025","article-title":"Interoperability of population-based patient registries","volume":"6","author":"Nicholson","year":"2020","journal-title":"J Biomed Informatics X"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8327980","article-title":"Linked registries: connecting rare diseases patient registries through a semantic web layer","volume":"2017","author":"Sernadela","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0027","unstructured":"SECURE-IBD. Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion. Updates on COVID-19 and IBD. Available at: https:\/\/covidibd.org. Accessed August 31, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaad.2020.03.004","article-title":"The alopecia areata consensus of experts (ACE) study: results of an international expert opinion on treatments for alopecia areata","volume":"83","author":"Meah","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/bjd.16714","article-title":"TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries","volume":"180","author":"Gerbens","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0031","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bjd.17715","article-title":"TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries","volume":"181","author":"Vermeulen","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0032","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13063-016-1765-7","article-title":"TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries","volume":"18","author":"Gerbens","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0033","doi-asserted-by":"crossref","unstructured":"Meah N, Wall D, York K, et\u00a0al. The alopecia areata consensus of experts (ACE) Study PART II: results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata [e-pub ahead of print]. J Am Acad Dermatol. doi: 10.1016\/j.jaad.2020.09.028, acessed XXXX.","DOI":"10.1016\/j.jaad.2020.09.028"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2020.5839","article-title":"A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)","volume":"157","author":"Wall","year":"2021","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0035","first-page":"20","article-title":"Improving interoperability between registries and EHRs","volume":"2017","author":"Blumenthal","year":"2018","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0036","doi-asserted-by":"crossref","first-page":"e20239","DOI":"10.2196\/20239","article-title":"Development of an openEHR template for COVID-19 based on clinical guidelines","volume":"22","author":"Li","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0037","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13023-019-1146-x","article-title":"Development of a pilot rare disease registry: a focus group study of initial steps towards the establishment of a rare disease ecosystem in Slovenia","volume":"14","author":"Stanimirovic","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0038","unstructured":"Physical Consortium for Performance Improvement. Registries on FHIR. https:\/\/www.thepcpi.org\/page\/RegistriesOnFHIR?&hhsearchterms=%22registries+and+fhir%22. Accessed August 31, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0039","unstructured":"SECURE-AD Registries. Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion. Coronavirus & Atopic Dermatitis Database. Available at: https:\/\/www.secure-derm.com\/secure-ad-physician\/. Accessed July 20, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0040","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/nm0111-4a","article-title":"A registry of registries? The US backs the idea for patients","volume":"17","author":"Heger","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0041","unstructured":"Orphanet. Search for a registry\/biobank. Available at: https:\/\/www.orpha.net\/consor\/cgi-bin\/ResearchTrials_RegistriesMaterials.php?lng=EN. Accessed August 31, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0042","unstructured":"Orphanet. About Orphanet. Available at: https:\/\/www.orpha.net\/consor\/cgi-bin\/Education_AboutOrphanet.php?lng=EN. Accessed August 31, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0043","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Available at: ENCePP Resources Database. http:\/\/www.encepp.eu\/encepp\/resourcesDatabase.jsp. Accessed July 10, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0044","unstructured":"European Medicines Agency. Patient registries. Available at: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/patient-registries. Accessed July 10, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0045","unstructured":"European Medicines Agency. ENCePP Resource Database. Inventory of Patient Registries. 2017. Available at: https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/encepp-resource-database-inventory-patient-registries_en.pdf. Accessed Month XX, 20XX."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0046","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pds.4381","article-title":"Strengthening standards, transparency, and collaboration to support medicine evaluation: ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)","volume":"27","author":"Kurz","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0047","unstructured":"Agency for Healthcare Research and Quality. Registry of patient registries. Available at: https:\/\/www.ahrq.gov\/ropr\/index.html. Accessed July 10, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0048","unstructured":"US National Library of Medicine. Available at: https:\/\/clinicaltrials.gov. Accessed July 10, 2020."},{"key":"10.1016\/j.clindermatol.2021.01.018_bib0049","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2016.03.020","article-title":"Review of patient registries in dermatology","volume":"75","author":"DiMarco","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X21000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:17:29Z","timestamp":1760033849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X21000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0738081X21000225"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.01.018","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learning from disease registries during a pandemic: Moving toward an international federation of patient registries","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2021.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}